Press Releases
Site - Investor Relations
Predictive Oncology Has Regained Compliance with Nasdaq’s Minimum Bid Price Requirement
The Company had previously received written notice from Nasdaq in
About
Forward-looking Statements
Certain of the matters discussed in this press release contain forward-looking statements that involve material risks to and uncertainties in the Company’s business that may cause actual results to differ materially from those anticipated by the statements made herein. Such risks and uncertainties include: market and other conditions and the intended use of net proceeds from the registered direct offering, a variety of other risks and uncertainties including, among other things, factors discussed under the heading “Risk Factors” in our filings with the
Investor Relations Contact:
(404) 995-6671
kpinder@landoncapital.net
Source: Predictive Oncology Inc.